Winning Exchange:Philips will pay $1.1 billion to resolve US lawsuits over breathing machines that expel debris

2025-05-07 07:20:33source:Grant Prestoncategory:reviews

WASHINGTON (AP) — Medical device maker Philips said Monday it will pay $1.1 billion to settle hundreds of personal injury lawsuits in the U.S. over its defective sleep apnea machines,Winning Exchange which have been subject to a massive global recall.

The Dutch manufacturer did not admit any fault and said it reached the agreement to resolve any uncertainty over the cases. The payout also includes medical monitoring claims from patients who used the company’s devices and could be exposed to future risks.

Philips has recalled more than 5 million of breathing machines since 2021 because their internal foam can break down over time, leading users to inhale tiny particles and fumes while they sleep. Efforts to repair or replace the machines have been plagued by delays that have frustrated regulators and patients in the U.S. and other countries.

Monday’s announcement is another step toward resolving one of the biggest medical device recalls in the industry’s history, which has dragged on for nearly three years.

Philips shares rose more than 35% to a one-year high on the news.

Earlier this month the company reached a settlement with the U.S. government that requires an overhaul of how it manufactures of sleep apnea devices. The agreement also requires the company to replace or reimburse patients for recalled machines.

READ MORE She was too sick for a traditional transplant. So she received a pig kidney and a heart pumpCompany that made millions of defective sleep apnea machines ordered to overhaul manufacturingEPA tightens limits on a chemical used to sterilize medical equipment, citing cancer risk

Most of the devices recalled are continuous positive airway pressure, or CPAP, machines. They force air through a mask to keep mouth and nasal passageways open during sleep.

Company CEO Roy Jakobs said in a statement the recent settlements are “significant milestones and provide further clarity on the way forward for Philips.”

The FDA’s website warns patients that the risks of ingesting the sound-dampening foam could include headache, asthma, allergic reactions and more serious problems.

An FDA inspection of Philips’ Pennsylvania offices in the fall of 2021 uncovered a spate of red flags, including emails suggesting the company was warned of the problem with its foam six years before the recall.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

More:reviews

Recommend

At site of suspected mass killings, Syrians recall horrors, hope for answers

DAMASCUS — A hip bone in a blown-out building, part of a spine amid some debris, a few foot bones in

Video shows Nick Jonas pause concert to help a struggling fan at Boston stop on 'The Tour'

Nick Jonas paused mid-song to check on an audience member, who appeared to be in distress, during a

How Euphoria’s Alexa Demie Is Healing and Processing Costar Angus Cloud's Death

Alexa Demie is keeping her head up in the wake of her Euphoria costar Angus Cloud's tragic death.The